CytoSorb therapy for infective endocarditis: Expectations and a question of patient phenotype?
Saved in:
| Main Authors: | Nandor Marczin, Shahzad Raja, Daniel Wendt, Harriet Adamson, Victoria Rizzo |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Elsevier
2025-05-01
|
| Series: | Cirugía Cardiovascular |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1134009624002018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemoadsorption Treatment with CytoSorb® in Probable Hemophagocytic Lymphohistiocytosis: A Role as Adjunctive Therapy?
by: Samuele Ceruti, et al.
Published: (2021-01-01) -
The Effect of Hemoadsorption with CytoSorb on Severe COVID-19 Complications
by: A. S. Rybalko, et al.
Published: (2024-09-01) -
Use of CytoSorb in Traumatic Amputation of the Forearm and Severe Septic Shock
by: Heinz Steltzer, et al.
Published: (2017-01-01) -
Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case
by: Catalin Gabriel Cirstoveanu, et al.
Published: (2017-01-01) -
The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences
by: Juan Carlos Ruiz-Rodríguez, et al.
Published: (2021-01-01)